FDA Calendar for Adeona Pharmaceuticals, Inc. (AEN)

| Register (free)
Adeona Pharmaceuticals, Inc. (Adeona) is a development-stage, specialty pharmaceutical company that is developing late-stage drug candidates for the treatment of opththalmic, neurologic and autoimmune diseases. The Company is a specialty pharmaceutical company that is preparing to commercialize a series of products for the prevention and treatment of degenerative conditions that the Company involve subclinical zinc deficiency and/or chronic copper toxicity. The Company conditions are highly prevalent and under-recognized in the aging population and that they may contribute to the progression of dry age-related macular degeneration (dry AMD), Alzheimer’s disease (AD), and mild cognitive impairment (MCI). Its product candidate brands, Zinthionein and EyeDaily with Zinthionein, are expected to be products that contain ingredients (such as, zinc monocysteine complex). In July 2009, Adeona completed the acquisition of HartLab LLC, an independent clinical laboratory.


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
This company currently does not have any drugs. If you would like to create one please click here.


Events

No future events listed at this time, please check back later.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

AEN

$2.30
0.13 +5.99%
2/3/2012 4:00:00 PM

Sponsors

Other Links